• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK XS PT TEST PST; PROTHROMBIN TIME MONITOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK XS PT TEST PST; PROTHROMBIN TIME MONITOR Back to Search Results
Catalog Number 07671687016
Device Problem High Test Results (2457)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 04/24/2023
Event Type  Injury  
Manufacturer Narrative
Occupation is patient/consumer.The meter and test strips were requested for investigation.No material was returned for the investigation.The patient was sent a different coaguchek inrange meter to perform comparison testing.The results from the patient¿s coaguchek inrange meter in question and the different coaguchek inrange meter were reportedly the same using 2 different strip lots.The specific results were not provided.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.Per product labeling, "coaguchek uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods." the patient has antiphospholipid antibody syndrome.Product labeling states: "the presence of antiphospholipid antibodies (apas) such as lupus antibodies (la) may lead to prolonged clotting times, i.E., they may cause false high inr values.If you have or suspect that you have apas, discontinue testing until you discuss with your physician.".
 
Event Description
We received an allegation that a patient was hospitalized for venous thrombosis while using coaguchek inrange meter serial number (b)(6).On (b)(6) 2023 the meter result was reportedly 3 inr.On (b)(6) 2023 the meter result was reportedly 3 inr.On (b)(6) 2023 the patient was reportedly hospitalized for venous thrombosis.The laboratory result at the hospital from an unknown method was reportedly 1.5 inr.On (b)(6) 2023 the meter result was reportedly 2.9 inr.Within 3 hours, the laboratory result from an unknown method was reportedly 1.5 inr.The specific details related to the patient's hospitalization (diagnostic tests, treatment received, and length of stay) were not provided.The patient¿s therapeutic range is reportedly 3 ¿ 4 inr.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK XS PT TEST PST
Type of Device
PROTHROMBIN TIME MONITOR
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key16977816
MDR Text Key315705198
Report Number1823260-2023-01709
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K170960
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 05/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/22/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date12/31/2023
Device Catalogue Number07671687016
Device Lot Number62215316
Was Device Available for Evaluation? No
Date Manufacturer Received04/25/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
WARFARIN
Patient Outcome(s) Hospitalization;
Patient SexMale
-
-